138 related articles for article (PubMed ID: 34454532)
1. Dimethyl fumarate inhibits antibody-induced platelet destruction in immune thrombocytopenia mouse.
Tong H; Ding Y; Gui X; Sun Z; Wang G; Zhang S; Xu Z; Wang X; Xu X; Ju W; Li Y; Li Z; Zeng L; Xu K; Qiao J
Thromb J; 2021 Aug; 19(1):61. PubMed ID: 34454532
[TBL] [Abstract][Full Text] [Related]
2. Thalidomide prevents antibody-mediated immune thrombocytopenia in mice.
Xu M; Wang X; Xu X; Wei G; Lu W; Luo Q; Li X; Liu Y; Ju W; Li Z; Xu K; Zeng L; Qiao J
Thromb Res; 2019 Nov; 183():69-75. PubMed ID: 31670229
[TBL] [Abstract][Full Text] [Related]
3. Tacrolimus ameliorates thrombocytopenia in an ITP mouse model.
Wang X; Lu J; Wei G; Tong H; Zhou J; Ding Y; Zhang S; Xu X; Lai R; Luo Q; Ju W; Yan Z; Zeng L; Xu K; Qiao J
Ann Hematol; 2020 Oct; 99(10):2315-2322. PubMed ID: 32728937
[TBL] [Abstract][Full Text] [Related]
4. Assessment of Th17/Treg cells and Th cytokines in an improved immune thrombocytopenia mouse model.
Zhang G; Zhang P; Liu H; Liu X; Xie S; Wang X; Wu Y; Chang J; Ma L
Hematology; 2017 Sep; 22(8):493-500. PubMed ID: 28300523
[TBL] [Abstract][Full Text] [Related]
5. Mouse immune thrombocytopenia is associated with Th1 bias and expression of activating Fcγ receptors.
Nishimoto T; Okazaki Y; Numajiri M; Kuwana M
Int J Hematol; 2017 May; 105(5):598-605. PubMed ID: 28028748
[TBL] [Abstract][Full Text] [Related]
6. Icaritin Improves Antibody-Induced Thrombocytopenia in a Mouse Model by Regulating T-cell Polarization.
Sun C; Yang J; Wang M; Pan L; Yao J; Wang S; Guo N; Li C; Zhang G
Planta Med; 2018 Feb; 84(3):168-175. PubMed ID: 28938496
[TBL] [Abstract][Full Text] [Related]
7. Imbalanced expression of Bcl-xL and Bax in platelets treated with plasma from immune thrombocytopenia.
Qiao J; Liu Y; Li D; Wu Y; Li X; Yao Y; Niu M; Fu C; Li H; Ma P; Li Z; Xu K; Zeng L
Immunol Res; 2016 Apr; 64(2):604-9. PubMed ID: 26712345
[TBL] [Abstract][Full Text] [Related]
8. β2-adrenergic receptor agonist corrects immune thrombocytopenia by reestablishing the homeostasis of T cell differentiation.
Zhang GC; Wu YJ; Liu FQ; Chen Q; Sun XY; Qu QY; Fu HX; Huang XJ; Zhang XH
J Thromb Haemost; 2023 Jul; 21(7):1920-1933. PubMed ID: 36972787
[TBL] [Abstract][Full Text] [Related]
9. The cytokines (IFN-gamma, IL-2, IL-4, IL-10, IL-17) and Treg cytokine (TGF-beta1) levels in adults with immune thrombocytopenia.
Ma L; Liang Y; Fang M; Guan Y; Si Y; Jiang F; Wang F
Pharmazie; 2014 Sep; 69(9):694-7. PubMed ID: 25272942
[TBL] [Abstract][Full Text] [Related]
10. Recognition of the human antibody-mediated platelet destruction in adult ITP patients by C-reactive protein.
Pan JQ; Wang W; Wang ML; Li XY; Wang JH; Zhao WW; Tian YY; Dong XS; Jiang YF
Int J Clin Exp Pathol; 2017; 10(10):10176-10185. PubMed ID: 31966351
[TBL] [Abstract][Full Text] [Related]
11. Thymic retention of CD4+CD25+FoxP3+ T regulatory cells is associated with their peripheral deficiency and thrombocytopenia in a murine model of immune thrombocytopenia.
Aslam R; Hu Y; Gebremeskel S; Segel GB; Speck ER; Guo L; Kim M; Ni H; Freedman J; Semple JW
Blood; 2012 Sep; 120(10):2127-32. PubMed ID: 22760780
[TBL] [Abstract][Full Text] [Related]
12. Mouse Models for Immune-Mediated Platelet Destruction or Immune Thrombocytopenia (ITP).
Neschadim A; Branch DR
Curr Protoc Immunol; 2016 Apr; 113():15.30.1-15.30.13. PubMed ID: 27038460
[TBL] [Abstract][Full Text] [Related]
13. CD4+CD25+Foxp3+ regulatory T cells in the pathophysiology of immune thrombocytopenia.
Nishimoto T; Kuwana M
Semin Hematol; 2013 Jan; 50 Suppl 1():S43-9. PubMed ID: 23664516
[TBL] [Abstract][Full Text] [Related]
14. The effect of dimethyl fumarate on gene expression and the level of cytokines related to different T helper cell subsets in peripheral blood mononuclear cells of patients with psoriasis.
Tahvili S; Zandieh B; Amirghofran Z
Int J Dermatol; 2015 Jul; 54(7):e254-60. PubMed ID: 26108267
[TBL] [Abstract][Full Text] [Related]
15. Platelet-Derived Growth Factor-BB Protects Mesenchymal Stem Cells (MSCs) Derived From Immune Thrombocytopenia Patients Against Apoptosis and Senescence and Maintains MSC-Mediated Immunosuppression.
Zhang JM; Feng FE; Wang QM; Zhu XL; Fu HX; Xu LP; Liu KY; Huang XJ; Zhang XH
Stem Cells Transl Med; 2016 Dec; 5(12):1631-1643. PubMed ID: 27471307
[TBL] [Abstract][Full Text] [Related]
16. Aberrant expression of RUNX3 in patients with immune thrombocytopenia.
Qiao J; Liu Y; Wu Y; Li X; Zhu F; Xia Y; Yao H; Chu P; Li H; Ma P; Li D; Li Z; Xu K; Zeng L
Int Immunopharmacol; 2015 Sep; 28(1):252-6. PubMed ID: 26093269
[TBL] [Abstract][Full Text] [Related]
17. Jianpi Yiqi Shexue ameliorates immune thrombocytopenia related fatigue by regulating mitochondrial function.
Zhang Y; Wang J; Gao J; Guo M; Chen H; Liu J; Li L; Liao J; Chen X; Lang H
Ann Palliat Med; 2021 Jan; 10(1):156-168. PubMed ID: 33440960
[TBL] [Abstract][Full Text] [Related]
18. Pathogenesis of chronic immune thrombocytopenia: increased platelet destruction and/or decreased platelet production.
Nugent D; McMillan R; Nichol JL; Slichter SJ
Br J Haematol; 2009 Sep; 146(6):585-96. PubMed ID: 19466980
[TBL] [Abstract][Full Text] [Related]
19. Allogeneic platelet transfusions prevent murine T-cell-mediated immune thrombocytopenia.
Guo L; Yang L; Speck ER; Aslam R; Kim M; McKenzie CG; Lazarus AH; Ni H; Hou M; Freedman J; Semple JW
Blood; 2014 Jan; 123(3):422-7. PubMed ID: 24258817
[TBL] [Abstract][Full Text] [Related]
20. [Effect and mechanism of low-dose chidamide on the treatment of primary immune thrombocytopenia].
Zhao HY; Li DQ; Wang J; Hou Y; Sun L; Peng J; Hou M
Zhonghua Xue Ye Xue Za Zhi; 2020 Apr; 41(4):292-296. PubMed ID: 32447932
[No Abstract] [Full Text] [Related]
[Next] [New Search]
